Known targets — ChEMBL curated mechanism
PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.59 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.42 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.42 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.42 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 10/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 5/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.41 |
| ▸ | DPP4 | P27487 | 4/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.38 |
| ▸ | FAP | Q12884 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lysine SCHEMBL3749535 | 0.98 | GSR (0.61) | GSRGNAI3GNAO1GNAI1RNPEP | |
| Lysine SCHEMBL3749539 | 0.98 | GSR (0.61) | GSRGNAI3GNAO1GNAI1RNPEP | |
| Lysine SCHEMBL9767819 | 0.96 | GSR (0.59) | GSRGNAI3GNAO1GNAI1RNPEP | |
| Lysine SCHEMBL7507173 | 0.94 | GSR (0.57) | GSRGNAI3GNAO1GNAI1RNPEP | |
| Lysine SCHEMBL25283016 | 0.93 | GSR (0.61) | GSRGNAI3GNAO1GNAI1RNPEP | |
| Lysine SCHEMBL121844 | 0.93 | GSR (0.61) | GSRGNAI3GNAO1GNAI1RNPEP | |
| Lysine SCHEMBL4400353 | 0.93 | GSR (0.61) | GSRGNAI3GNAO1GNAI1RNPEP | |
| Lysine SCHEMBL5691386 | 0.93 | GSR (0.61) | GSRGNAI3GNAO1GNAI1RNPEP | |
| Lysine SCHEMBL3517540 | 0.93 | GSR (0.61) | GSRGNAI3GNAO1GNAI1RNPEP | |
| Lysine SCHEMBL5148145 | 0.93 | GSR (0.61) | GSRGNAI3GNAO1GNAI1RNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260116846-A1 | PREPARATION OF A LYSINATE COMPOUND FROM AN AQUEOUS LYSINE SOLUTION | PHYTOBIOTICS FUTTERZUSATZSTOFFE GMBH (DE) | 2026-04-30 | — | — | US | disclosed |
| US-12497350-B2 | Preparation of a lysinate compound from an aqueous lysine solution | PHYTOBIOTICS FUTTERZUSATZSTOFFE GMBH (DE) | 2025-12-16 | — | — | US | disclosed |
| EP-3670494-B1 | PRODUCTION OF LYSINATE COMPOUND FROM AN AQUEOUS LYSIN SOLUTION | PHYTOBIOTICS FUTTERZUSATZSTOFFE GMBH (DE) | 2023-06-14 | — | — | EP | disclosed |
| US-20220024856-A1 | PREPARATION OF A LYSINATE COMPOUND FROM AN AQUEOUS LYSIN SOLUTION | PHYTOBIOTICS FUTTERZUSATZSTOFFE GMBH (DE) | 2022-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220024856-A1 | PREPARATION OF A LYSINATE COMPOUND FROM AN AQUEOUS LYSIN SOLUTION | LTN1, LCT, LPXN | GSR 4803/4885GNAI3 4261/4885GNAO1 4080/4885 |
| US-20260116846-A1 | PREPARATION OF A LYSINATE COMPOUND FROM AN AQUEOUS LYSINE SOLUTION | SLC6A9, SLC6A19, SLC39A14 | GSR 4531/4885GNAI3 4664/4885GNAO1 4498/4885 |
| US-12497350-B2 | Preparation of a lysinate compound from an aqueous lysine solution | KDM5A, KDM5B, KDM5C | GSR 4835/4885GNAI3 4543/4885GNAO1 4308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.